3020 POSTER Preliminary efficacy of Bevacizumab with first-line Folfox, Xelox, Folfiri and fluoropyrimidines for mCRC: First BEAT trialScott Berry, Eric Van Cutsem, Maasberg Michael et al.|European Journal of Cancer Supplements|2007Cited by 9